Philipp Markart

5.6k total citations
85 papers, 4.0k citations indexed

About

Philipp Markart is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, Philipp Markart has authored 85 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 14 papers in Hematology and 12 papers in Physiology. Recurrent topics in Philipp Markart's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Neonatal Respiratory Health Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Philipp Markart is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Neonatal Respiratory Health Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Philipp Markart collaborates with scholars based in Germany, Austria and United States. Philipp Markart's co-authors include Clemens Ruppert, Werner Seeger, Małgorzata Wygrecka, Andreas Güenther, Andreas Günther, Klaus T. Preissner, Ingrid Henneke, Friedrich Grimminger, Martina Korfei and Poornima Mahavadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Philipp Markart

78 papers receiving 3.9k citations

Peers

Countries citing papers authored by Philipp Markart

Since Specialization

Citations

This map shows the geographic impact of Philipp Markart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Markart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Markart more than expected).

Fields of papers citing papers by Philipp Markart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Markart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Markart. The network helps show where Philipp Markart may publish in the future.

Co-authorship network of co-authors of Philipp Markart

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Markart. A scholar is included among the top collaborators of Philipp Markart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Markart. Philipp Markart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers 2023 ·International Journal of Molecular Sciences ·Fotios Drakopanagiotakis, Philipp Markart, Paschalis Steiropoulos	13
2	Biomarkers in idiopathic pulmonary fibrosis 2018 ·Matrix Biology ·Fotios Drakopanagiotakis, Łukasz Wujak, Małgorzata Wygrecka, Philipp Markart	92
3	Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Dariusz Zakrzewicz, Anna Zakrzewicz, Miroslava Didiášová, (unknown), Djuro Kosanovic, Ralph T. Schermuly, Philipp Markart, Małgorzata Wygrecka	21
4	Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis 2014 ·European Respiratory Journal ·Clemens Ruppert, (unknown), Holger Nef, Werner Seeger, Andreas Güenther, Philipp Markart	1
5	Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts 2014 ·European Respiratory Journal ·(unknown), Fotios Drakopanagiotakis, (unknown), (unknown), Silke Tello, Daniel von der Beck, Werner Seeger, Philipp Markart, Andreas Güenther, Carlo Albera	1
6	Mast Cells and Fibroblasts Work in Concert to Aggravate Pulmonary Fibrosis 2013 ·American Journal Of Pathology ·Małgorzata Wygrecka, Bhola K. Dahal, Djuro Kosanovic, Frank Petersen, Brigitte Taborski, Susanne von Gerlach, Miroslava Didiášová, Dariusz Zakrzewicz, Klaus T. Preissner, Ralph T. Schermuly, Philipp Markart	85
7	PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension 2012 ·Circulation Research ·Grażyna Kwapiszewska, Philipp Markart, Bhola K. Dahal, Baktybek Kojonazarov, Leigh M. Marsh, Ralph T. Schermuly, Christian Taube, Andreas Meinhardt, Hossein Ardeschir Ghofrani, Martin Steinhoff, Werner Seeger, Klaus T. Preissner, Andrea Olschewski, Norbert Weißmann, Małgorzata Wygrecka	50
8	Disruption of Platelet-derived Chemokine Heteromers Prevents Neutrophil Extravasation in Acute Lung Injury 2012 ·American Journal of Respiratory and Critical Care Medicine ·Jochen Grommes, Jean-Éric Alard, Maik Drechsler, (unknown), Matthias Mörgelin, Wolfgang M. Kuebler, Michael J. Jacobs, Philipp von Hundelshausen, Philipp Markart, Małgorzata Wygrecka, Klaus T. Preissner, Tilman M. Hackeng, Rory R. Koenen, Christian Weber, Oliver Soehnlein	183
9	Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis 2011 ·American Journal of Respiratory and Critical Care Medicine ·Małgorzata Wygrecka, Grażyna Kwapiszewska, Ewa Jabłońska, Susanne von Gerlach, Ingrid Henneke, Dariusz Zakrzewicz, Andreas Güenther, Klaus T. Preissner, Philipp Markart	76
10	Shedding of Low-Density Lipoprotein Receptor–related Protein-1 in Acute Respiratory Distress Syndrome 2011 ·American Journal of Respiratory and Critical Care Medicine ·Małgorzata Wygrecka, Jochen Wilhelm, Ewa Jabłońska, Dariusz Zakrzewicz, Klaus T. Preissner, Werner Seeger, Andreas Güenther, Philipp Markart	39
11	Update in Diffuse Parenchymal Lung Disease 2010 2011 ·American Journal of Respiratory and Critical Care Medicine ·Philipp Markart, Małgorzata Wygrecka, Andreas Güenther	2
12	Inhibition of Urokinase Activity Reduces Primary Tumor Growth and Metastasis Formation in a Murine Lung Carcinoma Model 2010 ·American Journal of Respiratory and Critical Care Medicine ·Ingrid Henneke, Susanne Greschus, Rajkumar Savai, Martina Korfei, Philipp Markart, Poornima Mahavadi, Ralph T. Schermuly, Małgorzata Wygrecka, Jörg Stürzebecher, Werner Seeger, Andreas Günther, Clemens Ruppert	42
13	Epithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia 2010 ·American Journal of Respiratory and Critical Care Medicine ·Poornima Mahavadi, Martina Korfei, Ingrid Henneke, Gerhard Liebisch, Gerd Schmitz, Bernadette R. Gochuico, Philipp Markart, Savério Bellusci, Werner Seeger, Clemens Ruppert, Andreas Güenther	71
14	Dry powder aerosolization of a recombinant surfactant protein-C–based surfactant for inhalative treatment of the acutely inflamed lung* 2010 ·Critical Care Medicine ·Clemens Ruppert, (unknown), (unknown), Sebastian Schmidt, (unknown), (unknown), Ingrid Henneke, Philipp Markart, Irwin Reiss, Ralph T. Schermuly, Werner Seeger, Andreas Günther	26
15	Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis 2008 ·American Journal of Respiratory and Critical Care Medicine ·Martina Korfei, Clemens Ruppert, Poornima Mahavadi, Ingrid Henneke, Philipp Markart, Miriam Koch, György Láng, Ludger Fink, Rainer-Maria Bohle, Werner Seeger, Timothy E. Weaver, Andreas Güenther	388
16	Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases 2008 ·Thrombosis and Haemostasis ·Ewa Jabłońska, Andreas Güenther, Klaus Preissner, Philipp Markart, Małgorzata Wygrecka	73
17	Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis 2004 ·Toxicology and Applied Pharmacology ·Reinhold E. Schmidt, Clemens Ruppert, Philipp Markart, (unknown), Leander Ermert, Norbert Weißmann, Andreas Breithecker, Monika Ermert, Werner Seeger, Andreas Günther	41
18	Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits 2003 ·American Journal of Respiratory and Critical Care Medicine ·Andreas Günther, (unknown), Monika Ermert, Ralph T. Schermuly, Norbert Weißmann, Andreas Breithecker, Philipp Markart, Clemens Ruppert, Karin Quanz, Leander Ermert, Friedrich Grimminger, Werner Seeger	137
19	Mouse Lysozyme M Is Important in Pulmonary Host Defense against Klebsiella pneumoniae Infection 2003 ·American Journal of Respiratory and Critical Care Medicine ·Philipp Markart, Thomas R. Korfhagen, Timothy E. Weaver, Henry T. Akinbi	67
20	Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia: Comparison with the Acute Respiratory Distress Syndrome 2000 ·American Journal of Respiratory and Critical Care Medicine ·Andreas Günther, (unknown), S Heinemann, Clemens Ruppert, (unknown), Philipp Markart, Friedrich Grimminger, D. Walmrath, Bettina Temmesfeld‐Wollbrück, Werner Seeger	241

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact